[Pubmed] Therapies for myasthenia gravis: FcRn inhibition and beyond
Posté : 25 janv. 2025 12:00
Lancet Neurol. 2025 Feb;24(2):88-89. doi: 10.1016/S1474-4422(25)00001-8.
NO ABSTRACT
PMID:39862886 | DOI:10.1016/S1474-4422(25)00001-8
Source: https://pubmed.ncbi.nlm.nih.gov/3986288 ... t9+e462414